Online citations, reference lists, and bibliographies.
← Back to Search

Pharmacokinetic And Pharmacodynamic Changes In The Elderly

A. Hämmerlein, H. Derendorf, D. Lowenthal
Published 1998 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Age-related changes in pharmacokinetics principally affect drug absorption, distribution, metabolism and elimination. Changes in pharmacodynamics are primarily seen in the cardiovascular and neuroendocrine system. Age-dependent changes in the kinetics and dynamics of drugs acting on the cardiovascular system and central nervous system are common, and this review, while by no means exhaustive of the effects of drugs on all organ systems, is reflective of the principles and gives examples of the effects of age on these 2 major systems. While pharmacokinetic changes in the elderly are usually well characterised, pharmacodynamic changes are understood only in the most preliminary way. There has been relatively little research in this area of geriatric clinical pharmacology, and pharmacodynamic changes are still an area of investigation.
This paper references
10.1172/JCI102286
Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males.
D. Davies (1950)
10.1016/0002-9343(59)90346-8
Anatomy of body water and electrolytes.
I. Edelman (1959)
10.1093/GERONJ/18.1.1
Age differences in the water content of the body as related to basal oxygen consumption in males.
N. Shock (1963)
10.1111/j.1532-5415.1965.tb02665.x
THE EFFECT OF INCREASING AGE ON THE DISTRIBUTION OF PERIPHERAL BLOOD FLOW IN MAN
A. Bender (1965)
10.5555/URI:PII:0022214366900758
Influence of age, renal disease, hypertension, diuretics, and calcium on the antidiuretic responses to suboptimal infusions of vasopressin.
R. Lindeman (1966)
10.1111/j.1532-5415.1968.tb02776.x
EFFECT OF AGE ON INTESTINAL ABSORPTION: IMPLICATIONS FOR DRUG ABSORPTION IN THE ELDERLY
A. Bender (1968)
10.1136/bmj.4.5674.11
Creatinine clearance in renal disease. A reappraisal
K. E. Kim (1969)
10.1016/0002-9610(69)90078-6
The aging gastrointestinal tract.
M. C. Geokas (1969)
10.1016/0026-0495(70)90062-4
Adult lean body mass declines with age: some longitudinal observations.
G. Forbes (1970)
10.1136/bmj.3.5775.607
Effect of Age and Sex on Human Drug Metabolism
K. O’malley (1971)
10.1161/01.RES.29.4.424
Effect of Age and High Blood Pressure on Barorefiex Sensitivity in Man
B. Gribbin (1971)
10.1038/KI.1975.120
Effect on aging on plasma renin and aldosterone in normal man.
P. Weidmann (1975)
The effect of dietary sodium chloride on blood pressure, body fluids, electrolytes, renal function, and serum lipids of normotensive man.
A. Kirkendall (1976)
10.1111/J.1365-2125.1976.TB00611.X
Factors affecting drug binding in plasma of elderly patients.
S. Wallace (1976)
10.1093/GERONJ/31.2.155
The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study.
J. Rowe (1976)
10.1161/01.CIR.54.4.624
Nitroglycerin‐induced Severe Hypotension and Bradycardia in Patients with Acute Myocardial Infarction
P. Come (1976)
10.1159/000180580
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft Dw (1976)
10.1038/261333a0
Plasma noradrenaline increases with age
M. Ziegler (1976)
10.1159/000180731
The influence of age on the renal response to water deprivation in man.
J. Rowe (1976)
10.1111/J.1365-2125.1977.TB00786.X
The influence of age on the response to anticoagulants.
S. Husted (1977)
10.1146/annurev.pa.17.040177.000405
Pharmacokinetic Consequences of Aging
Richey Dp (1977)
10.1111/J.1365-2125.1977.TB00719.X
Age as a determinant of sensitivity to warfarin.
A. Shepherd (1977)
10.1136/bmj.1.6052.10
Increased sensitivity to nitrazepam in old age.
C. Castleden (1977)
10.1111/j.2042-7158.1978.tb13240.x
Tissue distribution of radioactivity after injection of [14C]nitrazepam in young and old rats
D. Hewick (1978)
10.1002/cpt1978234371
Relationship between diazepam dose, plasma level, age, and central nervous system depression
M. Reidenberg (1978)
10.1177/003693307902400310
Clinical Pharmacology in the Elderly
C. Swift (1979)
10.1007/978-1-349-03813-8
Drugs and the Elderly
J. Crooks (1979)
10.1002/cpt197926116
Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination
A. Wood (1979)
10.1002/cpt19792618
Effects of age and cigarette smoking on propranolol disposition
R. Vestal (1979)
10.1111/J.1365-2125.1979.TB00896.X
The effect of ageing on the hepatic clearance of propranolol.
C. Castleden (1979)
10.1002/cpt1979262181
Reduced β‐adrenoceptor sensitivity in the elderly
R. Vestal (1979)
10.1038/clpt.1980.40
Diazepam disposition determinants
D. Greenblatt (1980)
10.1136/sti.56.6.355
Kinetic study of serum penicillin concentrations after single doses of benzathine and benethamine penicillins in young and old people.
P. Collart (1980)
10.1152/AJPHEART.1980.239.4.H501
Contractile and biochemical correlates of beta-adrenergic stimulation of the aged heart.
T. Guarnieri (1980)
10.1016/0197-4580(80)90019-6
Brain cholinergic dysfunction and memory in aged rats
A. Lippa (1980)
10.2165/00003088-198005030-00004
Disease-induced Changes in the Plasma Binding of Basic Drugs
K. Piafsky (1980)
10.1056/NEJM198005223022105
Nonsteroidal Antiinflammatory Drugs
L. Simon (1980)
10.1093/JAC/6.4.543
The pharmacokinetics of cefuroxime in the elderly.
J. Douglas (1980)
10.2165/00003088-198106050-00005
Disposition of Antipyrine and Phenytoin Correlated with Age and Liver Volume in Man
B. Bach (1981)
10.1111/j.1532-5415.1981.tb01766.x
Gastric Emptying Rate in the Elderly: Implications for Drug Therapy
M. A. Evans (1981)
10.1042/CS0600571
Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjects.
P. van Brummelen (1981)
10.1111/j.2042-7158.1981.tb13711.x
Brain benzodiazepine receptor changes during ageing
M. Memo (1981)
Effect of age on the pharmacokinetics and sedative of flunitrazepam.
J. Kanto (1981)
10.1159/000182197
Estimation of glomerular filtration rate by serum creatinine and serum beta 2-microglobulin.
B. Trollfors (1981)
10.1097/00005344-198200433-00018
The place of the calcium antagonist verapamil in antihypertensive therapy.
F. Bühler (1982)
The Causes of Cancer
M. R. Hall (1982)
10.1093/GERONJ/37.2.156
Isoproterenol responsiveness and myocardial beta-adrenergic receptors in young and old rats.
I. Abrass (1982)
10.1038/clpt.1982.24
Acetaminophen kinetics in the elderly
M. Divoll (1982)
10.1016/0047-6374(82)90086-0
Changes in the mechanisms of hormone and neurotransmitter action during aging: Current status of the role of receptor and post-receptor alterations. A review
G. Roth (1982)
10.1210/JCEM-55-5-1026
Catalytic unit of adenylate cyclase: reduced activity in aged-human lymphocytes.
I. Abrass (1982)
10.1210/JCEM-54-3-661
Age-related failure of volume-pressure-mediated vasopressin release.
J. Rowe (1982)
10.1016/0021-9681(83)90047-4
Aging and drug disposition--pharmacodynamics.
J. Crooks (1983)
Alpha 1 -acid glycoprotein and binding of basic drugs.
Paxton Jw (1983)
10.1161/01.HYP.5.5.763
Baroreflex function in elderly hypertensives.
K. Mcgarry (1983)
10.1001/JAMA.1984.03340340033021
Drug use in the United States in 1981.
C. Baum (1984)
10.1056/NEJM198402023100502
Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin.
G. Ciabattoni (1984)
10.1111/J.1445-5994.1984.TB04290.X
Drug therapy in the elderly.
P. Ho (1984)
10.1111/J.1365-2125.1984.TB02397.X
Impaired enzyme induction by rifampicin in the elderly.
Y. Twum-Barima (1984)
10.1001/ARCHINTE.1984.00350160129021
Orthostatic hypotension. I. Functional and neurogenic causes.
I. Schatz (1984)
10.1056/NEJM198403293101303
Alterations in leukocyte β-receptor affinity with aging: a potential explanation for altered β-adrenergic sensitivity in the elderly
R. Feldman (1984)
10.1136/bmj.289.6441.351
Diazepam tolerance: effect of age, regular sedation, and alcohol.
P. Cook (1984)
10.1001/ARCHINTE.144.5.1037
Orthostatic Hypotension: II. Clinical Diagnosis, Testing, and Treatment
I. Schatz (1984)
Imipramine and desipramine disposition in the elderly.
D. Abernethy (1985)
10.1136/BMJ.291.6496.661
Non-oliguric renal failure during treatment with mefenamic acid in elderly patients: a continuing problem.
A. Taha (1985)
Aging and drug disposition: an update.
D. L. Schmucker (1985)
Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man.
H. Pan (1986)
10.7326/0003-4819-107-2-169
Adverse drug reactions associated with global cognitive impairment in elderly persons.
E. Larson (1987)
10.2165/00003088-198815030-00002
Digitalis. An update of clinical pharmacokinetics, therapeutic monitoring techniques and treatment recommendations.
A. Mooradian (1988)
10.1093/GERONJ/43.1.M18
The effect of age on serum albumin in healthy males: report from the Normative Aging Study.
E. Campion (1988)
10.1111/J.1365-2125.1988.TB03307.X
Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine.
D. Robertson (1988)
10.1111/j.1532-5415.1988.tb04379.x
Decreased Receptor Activation with Age
P. Scarpace (1988)
10.1097/00005344-198806124-00028
The effects of age and race on nitrendipine pharmacokinetics and pharmacodynamics.
J. Lettieri (1988)
10.1093/GERONJ/44.1.M13
Comparison of age-related changes in prostaglandin E1 and beta-adrenergic responsiveness of vascular smooth muscle in adult males.
A. Hiremath (1989)
Aging: ouabain-sensitive 86Rb+ uptake rate and responsiveness to digoxin in rat left atrial muscle.
R. Kennedy (1989)
10.1097/00005344-198900134-00004
Calcium antagonists in the treatment of hypertension and angina pectoris in the elderly.
Elliott Hl (1989)
10.1001/JAMA.1989.03430230088031
Benzodiazepines of long and short elimination half-life and the risk of hip fracture.
W. Ray (1989)
10.1111/j.1532-5415.1989.tb05498.x
Drug‐Induced Illness as a Cause for Admission to a Community Hospital
H. Colt (1989)
10.1016/S0749-0690(18)30616-5
Altered pharmacodynamics in the elderly.
J. Feely (1990)
10.1016/S0749-0690(18)30615-3
Altered pharmacokinetics in the elderly.
G. Yuen (1990)
Understanding digoxin use in the elderly patient.
P. Tsang (1990)
10.1016/0002-9149(90)91306-Q
Nitrate therapy in the elderly.
J. Alpert (1990)
10.1038/clpt.1990.164
Effects of age and gender on in vitro properties of human liver microsomal monooxygenases
D. L. Schmucker (1990)
10.1016/S0749-0690(18)30623-2
Nonsteroidal anti-inflammatory drugs.
M. Murray (1990)
10.1111/j.1476-5381.1990.tb14135.x
Reduced high‐affinity α1‐adrenoceptors in liver of senescent rats: implications of assessment at various temperatures
S. Borst (1990)
10.1177/106002809002400127
Bedside Clinical Pharmacokinetics
D. Edwards (1990)
10.1007/978-3-662-38445-9_8
Mechanisms of altered hormone-neurotransmitter action during aging: from receptors to calcium mobilization.
G. Roth (1990)
10.2165/00002018-199005060-00003
Adverse drug reactions. An overview of special considerations in the management of the elderly patient.
Brawn La (1990)
10.1111/j.1749-6632.1990.tb48355.x
Opioid Peptides and Aging
J. Morley (1990)
10.1111/j.1532-5415.1991.tb03576.x
Benign Prostatic Hyperplasia: Pathogenesis and Medical Therapy
J. Geller (1991)
10.1002/J.1875-9114.1991.TB02631.X
Perspectives on Geriatric Pharmacotherapy
J. Delafuente (1991)
10.2165/00003088-199121040-00003
Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly
D. Greenblatt (1991)
10.1111/J.1365-2125.1992.TB04004.X
Age-related changes in adenosine and beta-adrenoceptor responsiveness of vascular smooth muscle in man.
G. Ford (1992)
10.2165/00002512-199202010-00003
Nitrates in the Elderly
J. Kelly (1992)
10.1146/ANNUREV.PA.32.040192.001415
Geriatric pharmacology: basic and clinical considerations.
N. Tumer (1992)
10.1111/j.1749-6632.1992.tb38671.x
Changes in Calcium's Role As a Messenger during Aging in Neuronal and Nonneuronal Cells a
C. Peterson (1992)
Aging effects on stereoselective pharmacokinetics and pharmacodynamics of verapamil.
J. Schwartz (1993)
10.1111/j.1532-5415.1993.tb06454.x
The Use of Intramuscular Cefoperazone versus Intramuscular Ceftriaxone in Patients with Nursing Home‐Acquired Pneumonia
S. L. Phillips (1993)
10.1016/0163-7258(93)90029-D
Ageing, late-onset asthma and the beta-adrenoceptor.
M. Connolly (1993)
10.1111/J.1365-2125.1993.TB04218.X
The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril.
N. J. Macdonald (1993)
10.1042/CS0870297
Effect of 'autonomic blockade' on cardiac beta-adrenergic chronotropic responsiveness in healthy young, healthy elderly and endurance-trained elderly subjects.
G. Ford (1994)
10.1136/thx.49.1.26
Peripheral mononuclear leucocyte beta adrenoceptors and non-specific bronchial responsiveness to methacholine in young and elderly normal subjects and asthmatic patients.
M. Connolly (1994)
10.1002/j.1552-4604.1995.tb04124.x
Effect of Aging on Atenolol Pharmacokinetics and Pharmacodynamics
K. M. Sowinski (1995)
10.2165/00003088-199529030-00005
Geographical/Interracial Differences in Polymorphic Drug Oxidation
L. Bertilsson (1995)
10.2165/00003088-199631050-00004
Pharmacokinetic Changes in the Elderly
V. Özdemir (1996)
10.1007/s002280050067
The effect of aging on the pharmacokinetics and pharmacodynamics of prazosin
E. Andros (1996)
10.1097/00045391-199612000-00008
THERAPEUTIC DRUG MONITORING IN THE ELDERLY
J. Ruiz (1996)
10.1016/S0009-9236(97)90166-1
Age and cytochrome P450‐linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions
E. Sotaniemi (1997)



This paper is referenced by
10.3390/antibiotics10050540
Serious Neurological Adverse Events of Ceftriaxone
Clémence Lacroix (2021)
10.1016/j.eplepsyres.2020.106478
Comparative analysis of the safety and tolerability of eslicarbazepine acetate in older (≥60 years) and younger (18–59 years) adults
E. Andermann (2021)
10.1007/s40262-020-00963-2
Population Pharmacokinetics of Levetiracetam: A Systematic Review
Zi-Ran Li (2021)
10.3389/fphar.2021.635165
Pharmacokinetic and Pharmacodynamic Considerations in Relation to Calcineurin Usage in Elderly Kidney Transplant Recipients
A. Cossart (2021)
10.1016/J.PHCLIN.2021.03.002
Réévaluation des prescriptions médicamenteuses chez le sujet âgé : bilan partagé de médication en officine et revue de médication en établissement de santé
L. Mondet (2021)
10.1155/2021/8661098
Age and Sex Variation in the Duration of Action and Corneal Touch Threshold (CTT) following Instillation of 0.5% Topical Ophthalmic Proparacaine and Tetracaine Hydrochlorides
S. Kyei (2021)
10.1101/2020.08.05.20167239
A Review of Population Pharmacokinetic Studies of Levetiracetam
Z. Li (2020)
10.1007/s40266-020-00756-z
Benzodiazepine Prescribing in People with Chronic Obstructive Pulmonary Disease: Clinical Considerations
D. Currow (2020)
Clinico- Pharmacologic Score Predicting Outcomes in Hospital Admitted Patients: Study from a Tertiary Centre
Sharma (2020)
10.1016/J.POP.2020.08.006
Renal Repercussions of Medications.
R. Shaddock (2020)
10.1017/9781911623465.009
Drugs to Treat Depression
P. Mclaughlin (2020)
10.2217/pgs-2019-0198
Challenges in pharmacotherapy for older adults: a framework for pharmacogenomics implementation.
Youssef M Roman (2020)
10.1111/bcp.14609
Development of a physiologically based pharmacokinetic (PBPK) population model for Chinese elderly subjects
Cheng Cui (2020)
10.9734/jpri/2020/v32i830468
Optimizing the Use of Hydroxychloroquine in the Management of COVID-19 Given Its Pharmacological Profile
A. Ali (2020)
10.47855/10.47855/jal9020-2020-1-6
Age peculiarities of pharmacokinetics and pharmacodynamics of medicines
L. Kuprash (2020)
Fentanyl Pharmacokinetics : the role of clinical factors in patients with cancer using transdermal or sublingual fentanyl
E. Kuip (2019)
10.1007/978-3-319-95114-0_48
Management Strategies in Geriatric Trauma Care
M. Joyce (2019)
10.1016/j.jiac.2019.09.010
Pharmacokinetic study of lascufloxacin in non-elderly healthy men and elderly men.
K. Totsuka (2019)
10.1097/MD.0000000000014136
Population pharmacokinetics and individualized lobaplatin regimen for the treatment of Chinese small cell lung cancer in the elderly
Y. Cheng (2019)
10.1016/j.sapharm.2019.01.004
Understanding the knowledge, attitudes and beliefs of community-dwelling older adults and their carers about the modification of oral medicines: A qualitative interview study to inform healthcare professional practice.
A. Mc Gillicuddy (2019)
10.1001/jamanetworkopen.2019.14745
Demographic Characteristics of Participants in Rheumatoid Arthritis Randomized Clinical Trials
A. Strait (2019)
10.1111/jep.12942
The Electronic Pharmaceutical Record: A new method for medication reconciliation
C. Jurado (2018)
10.1007/978-3-319-71694-7_5
Pharmacological Treatment of Pain
G. Pickering (2018)
10.1016/j.ejps.2017.10.015
Current strategies to streamline pharmacotherapy for older adults.
Jan-F Schlender (2018)
10.1007/978-3-030-03916-5_13
The Mismanagement of Multiple Medications in the Older Adult Population
N. Jamshed (2018)
10.1007/978-3-319-20317-1_12-1
Medication-Related Problems in Surgical Patients
S. Jeffery (2018)
10.5220/0008240301120116
Identification of Potentially Inappropriate Prescribing in Outpatient Geriatric using STOPP/START Criteria at X Hospital Jakarta
Numlil Khaira Rusdi (2018)
Chapter 4 An Overview of Polypharmacy in Geriatric Patients
B. Sahne (2018)
10.1016/j.addr.2018.09.003
Challenges and innovations of drug delivery in older age
M. S. Khan (2018)
10.1007/978-3-319-71694-7
Pain Management in Older Adults
Gis le. Pickering (2018)
10.1016/B978-0-12-803348-7.00020-4
Individualizing Drug Therapy in the Elderly
P. Maire (2017)
10.2174/1389557516666161013110813
Current State and Future Perspectives in QSAR Models to Predict Blood- Brain Barrier Penetration in Central Nervous System Drug R&D.
J. F. Morales (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar